Document is current
Any future updates will be listed below
-
Authors
Tuechler, Nadine https://orcid.org/0000-0002-8125-3098
Burtscher, Mira Lea https://orcid.org/0000-0003-2628-0795
Garrido-Rodriguez, Martin
Khan, Muzamil Majid https://orcid.org/0000-0002-8188-0251
Türei, Dénes https://orcid.org/0000-0002-7249-9379
Tischer, Christian
Kaspar, Sarah https://orcid.org/0009-0005-9745-6673
Schwarz, Jennifer Jasmin https://orcid.org/0000-0002-2406-0185
Stein, Frank https://orcid.org/0000-0001-9695-1692
Rettel, Mandy https://orcid.org/0000-0002-8304-3385
Kramann, Rafael https://orcid.org/0000-0003-4048-6351
Savitski, Mikhail M https://orcid.org/0000-0003-2011-9247
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Pepperkok, Rainer https://orcid.org/0000-0002-9762-3583
- License Information
-
More Information
Article History
Received: 3 February 2025
Revised: 18 April 2025
Accepted: 25 April 2025
First Online: 5 June 2025
Disclosure and competing interests statement
: JSR reports funding from GSK, Pfizer, and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Pfizer, Moderna, Grunenthal, Tempus, and Owkin.
